SPC449
Tislelísúmab
Status:
VeittApplication date:
6.12.2023Application published:
15.1.2024Grant published:
15.8.2025
Max expiry date:
12.9.2038Medicine name:
TevimbraMedicine for children:
No
Timeline
Today
6.12.2023Application
15.1.2024Publication
15.8.2025Registration
12.9.2038Expires
Marketing license
IS authorization number:
EU/1/23/1758Date:
19.10.2023
Foreign authorization number:
EU/1/23/1758Date:
15.9.2023
Owner
Name:
BeOne Medicines I GmbHAddress:
Aeschengraben 27, 4051 Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3702373
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 18.07.2025